Clinical trial
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced…
NCT00079027 · University Hospital Birmingham, Other · Unknown status
Key facts
| NCT number | NCT00079027 |
|---|---|
| Title | Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) |
| Official title | A Randomized Clinical Trial Evaluating the Benefits of Doxorubicin Chemoembolization Versus Systemic Doxorubicin in Patients With Unresectable, Advanced Hepatocellular Carcinoma |
| Lead sponsor | University Hospital Birmingham, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug, Procedure |
| Interventions | doxorubicin hydrochloride, hepatic artery embolization |
| Enrollment | 280 |
| Start date | Apr 1, 2004 |
| First posted | Mar 9, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: